Skip to main navigation Skip to search Skip to main content

Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: A randomised, placebo controlled, double blind, six month study

  • UK-Irish Entacapone Study Group
  • , Patricia Fitzgerald
  • Imperial College Healthcare NHS Trust
  • University of Sheffield

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: A randomised, placebo controlled, double blind, six month study'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience